Literature DB >> 12920

A preliminary evaluation of the anxiolytic activity of clobazam.

K Sandler, D Brunswick, J Digiacomo, J Mendels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 12920

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  5 in total

1.  [Analytical data of the new 1,5-benzodiazepine clobazam (Frisium) and its main metabolite nor-clobazam (author's transl)].

Authors:  H Schütz
Journal:  Arch Toxicol       Date:  1978-12-28       Impact factor: 5.153

2.  Clobazam: uncontrolled and standard controlled clinical trials.

Authors:  T A Ban; M M Amin
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Review of clinical studies on clobazam.

Authors:  D Koeppen
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

4.  The effects of repeated nocturnal doses of clobazam, dipotassium chlorazepate and placebo on subjective ratings of sleep and early morning behaviour and objective measures of arousal, psychomotor performance and anxiety.

Authors:  I Hindmarch; A C Parrott
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

Review 5.  Clobazam: a review of its pharmacological properties and therapeutic use in anxiety.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-09       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.